RIM
AZN icon

Redwood Investment Management’s AstraZeneca AZN Stock Holding History

Redwood Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$468K Sell
2,373
-1
-0% -$193 0.06% 235
2025
Q4 		$436K Sell
2,374
-32
-1% -$5.61K 0.05% 268
2025
Q3 		$369K Buy
2,406
+47
+2% +$7.11K 0.04% 251
2025
Q2 		$330K Hold
2,359
– – 0.04% 256
2025
Q1 		$347K Buy
2,359
+32
+1% +$4.63K 0.04% 252
2024
Q4 		$305K Hold
2,327
– – 0.03% 292
2024
Q3 		$362K Sell
2,327
-4
-0.2% -$646 0.03% 294
2024
Q2 		$364K Buy
2,331
+18
+0.8% +$2.71K 0.03% 300
2024
Q1 		$313K Buy
+2,313
New +$306K 0.03% 300

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Redwood Investment Management's AZN Position: Q1 2026 in Review

Redwood Investment Management reduced its AstraZeneca (AZN) stake by 0.04% in Q1 2026, selling an estimated $193 and leaving 2,373 shares worth $468K. The position accounts for 0.06% of the portfolio, ranked #235.

Redwood Investment Management first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. 1,382 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Redwood Investment Management held 2,373 shares of AstraZeneca worth $468K as of Q1 2026.
  • Redwood Investment Management sold 1 AstraZeneca share in Q1 2026, an estimated $193.
  • AstraZeneca made up 0.06% of Redwood Investment Management's portfolio in Q1 2026, its #235 holding.
  • Redwood Investment Management first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
  • 1,382 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Redwood Investment Management's 13F filing for Q1 2026, filed 14 May 2026.